Get access

Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure

Authors

  • Gideon St.Helen,

    1. Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA
    Search for more papers by this author
  • Delia Dempsey,

    1. Department of Bioengineering and Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, University of California, San Francisco, CA, USA
    Search for more papers by this author
  • Margaret Wilson,

    1. Department of Bioengineering and Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, University of California, San Francisco, CA, USA
    Search for more papers by this author
  • Peyton Jacob III,

    1. Department of Bioengineering and Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, University of California, San Francisco, CA, USA
    Search for more papers by this author
  • Neal L. Benowitz

    Corresponding author
    1. Department of Bioengineering and Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, University of California, San Francisco, CA, USA
    2. Department of Medicine, Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, University of California, San Francisco, CA, USA
    • Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA
    Search for more papers by this author

Correspondence to: Neal L. Benowitz, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, Box 1220, San Francisco, CA 94143-1220, USA. E-mail: nbenowitz@medsfgh.ucsf.edu

Abstract

Aims

To investigate the relationships between tobacco dependence, biomarkers of nicotine and carcinogen exposure and biomarkers of nicotine and carcinogen exposure per cigarette in back and white smokers.

Design, setting and participants

A total of 204 healthy black (n = 69) and white (n = 135) smokers were enrolled into two clinical studies.

Measurement

Nicotine equivalents (nicotine and its metabolites), 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol (NNAL) and polycyclic aromatic hydrocarbon (PAH) metabolites were measured in urine. The Fagerström Test for Nicotine Dependence (FTND) and time to first cigarette (TFC) measured tobacco dependence.

Findings

Average TFC and FTND for blacks and whites were not significantly different. Urine NNAL and nicotine equivalents increased with increasing FTND in whites but did not increase in blacks (race × FTND interaction, both P < 0.031). The interaction term was not significant for PAHs. An inverse relationship was seen between FTND and nicotine equivalents, NNAL and PAH metabolites per cigarette in blacks but remained flat in whites (race × FTND interaction, all P ≤ 0.039). Regardless of dependence (low dependence, TFC >15 minutes; high dependence, TFC ≤15 minutes), FTND and TFC were not correlated significantly with urine nicotine equivalents and carcinogen exposure in blacks. We found moderate correlations between FTND and TFC and nicotine equivalents and carcinogen exposure among whites of low dependence and non-significant correlations among whites of high dependence.

Conclusion

In the United States, tobacco dependence measures were related linearly to nicotine intake and carcinogen exposure in white but not in black smokers. The relationship between dependence measures and tobacco biomarkers in black smokers regardless of level of dependence resembled highly dependent white smokers.

Ancillary